ACARIZAX

Active ingredients

The drug ACARIZAX contains a combination of these active pharmaceutical ingredients (APIs):

UNII PR9U2YPF3Q - DERMATOPHAGOIDES FARINAE
UNII 57L1Z5378K - DERMATOPHAGOIDES PTERONYSSINUS

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ACARIZAX Oral lyophilisate
Summary of Product Characteristics (SPC)
UK

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
V01AA03
House dust
V Various → V01 Allergens → V01A Allergens → V01AA Allergen extracts
Discover more medicines within V01AA03

Authorization and marketing

This brand name is authorized in the following countries: Austria Canada Finland France Hong Kong Ireland Netherlands New Zealand Poland Romania Turkey

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02463644
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 186748, 555047
FR
Base de données publique des médicaments
Identifier(s): 67813445
HK
Department of Health Drug Office
Identifier(s): 65924
NL
Z-Index G-Standaard, PRK
Identifier(s): 205400
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 18800
PL
Rejestru Produktów Leczniczych
Identifier(s): 100330160
RO
Agenția Națională a Medicamentului și a Dispozitivelor Medicale
Identifier(s): W67212001, W67212002, W67212003
TR
İlaç ve Tıbbi Cihaz Kurumu
Identifier(s): 8681078093945, 8681078093952, 8681078093969